In addition, Ntrk2 was identified as one of eighteen genes that could replace EGFR dependence in NSCLC and these genes replace EGFR dependence by stimulating EGFR-independent signaling through MEK-ERK and PI3K-AKT signaling [106]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.